je.st
news
Tag: squibb
Analyst Update: Bristol-Myers Squibb Co, Achillion Pharmaceuticals, Inc., and Kimberly Clark Corp
2014-12-24 16:05:09| Paper - Topix.net
Bristol-Myers Squibb Co has been on a tear recently , outperforming the S&P 500 Index by more than 12 percentage points in the last 60 sessions. However, despite this morning's positive attention -- and the fact it touched a 13-year high of $61.77 out of the gate -- BMY has followed its pharmaceutical peers into the red , last seen at $58.74.
Tags: update
corp
clark
analyst
Cancer therapy deal with Bristol-Myers Squibb boosts Five Prime drug
2014-11-25 08:34:39| Biotech - Topix.net
Five Prime Therapeutics Inc. snagged a deal with Bristol-Myers Squibb Co. around one of the leading drugs in the emerging class of cancer-fighting drugs known as immune checkpoint inhibitors.
Bristol-Myers Squibb to Construct a New Large-Scale Biologics...
2014-11-14 14:19:50| Biotech - Topix.net
Bristol-Myers Squibb Company today announced plans to construct a new state-of-the-art, large-scale biologics manufacturing facility in Cruiserath, County Dublin, Ireland, that will produce multiple therapies for the company's growing biologics portfolio. Once completed, the new facility will significantly increase Bristol-Myers Squibb's biologics manufacturing capacity and play a central role in its global manufacturing network.
Tags: construct
squibb
biologics
largescale
Bristol-Myers Squibb Reports Third Quarter 2014 Financial Results
2014-10-24 22:39:51| Biotech - Topix.net
Bristol-Myers Squibb Company today reported strong financial results for the third quarter of 2014, adjusted 2014 GAAP guidance and confirmed 2014 non-GAAP guidance. The quarter was highlighted by strong performance by key brands, significant data and regulatory milestones for Opdivo , the launch of the company's hepatitis C regimens in Japan and Europe and the completion of several business development transactions supporting the company's oncology portfolio.
Tags: results
reports
financial
quarter
Analyst Upgrades: Baidu Inc (ADR), Bristol-Myers Squibb Co, and Tiffany & Co.
2014-10-16 18:00:38| Jewelry - Topix.net
Eleven of the 13 analysts following Baidu Inc have given it a "strong buy" endorsement, compared to two "holds" and not a single "sell" recommendation. Despite a nearly 8% year-to-date deficit to rest at $48.96, BMY was upgraded to "outperform" at BMO.
Tags: co
analyst
upgrades
tiffany